Cisatracurium Kabi is contraindicated in patients with known hypersensitivity to cisatracurium besylate, other bis-benzylisoquinolinium agents (e.g., atracurium), or any ingredient in the formulation.
Sign up for Free to continue reading
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
